Back
Calamos Convertible & High Income Fund Vs. Neurogene Industry Stock Comparison
Sell
50
CHY
Calamos Convertible & High Income Fund
Last Price:
11.93
Seasonality Move:
2.85%
Sell
1
NGNE
Neurogene
Last Price:
34.67
Seasonality Move:
50.43%
Sell
50
Calamos Convertible & High Income Fund (CHY)
is a Sell
Is Calamos Convertible & High Income Fund a Buy, Sell or Hold?
- The current Calamos Convertible & High Income Fund [CHY] share price is $11.95. The Score for CHY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- CHY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CHY Stock Price Chart
What is Calamos Convertible & High Income Fund's stock price today?
-
The Calamos Convertible & High Income Fund share price today is $11.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHY is experiencing slight selling pressure.
CHY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 45.77 | Sell |
| Chaikin Money Flow: | -26534 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.93 - 12.23) | Sell |
| Bollinger Bands (100): | (11.34 - 12.04) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 35.74 | Sell |
| Chaikin Money Flow: | -452975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.4 - 61.5) | Sell |
| Bollinger Bands (100): | (34.32 - 50.52) | Sell |
CHY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.16 | Sell |
| 20-day SMA: | 12.06 | Sell |
| 50-day SMA: | 11.99 | Sell |
| 200-day SMA: | 11.6 | Buy |
| 8-day EMA: | 12.1 | Sell |
| 20-day EMA: | 12.08 | Sell |
| 50-day EMA: | 11.96 | Sell |
| 200-day EMA: | 11.64 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.3 | Sell |
| 20-day SMA: | 51.47 | Sell |
| 50-day SMA: | 46.76 | Sell |
| 200-day SMA: | 38.99 | Sell |
| 8-day EMA: | 47.13 | Sell |
| 20-day EMA: | 50.2 | Sell |
| 50-day EMA: | 47.47 | Sell |
| 200-day EMA: | 38.44 | Sell |
Calamos Convertible & High Income Fund Earnings Growth & CHY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Calamos Convertible & High Income Fund Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||